The importance of being (slightly) modified: The role of rRNA editing on gene expression control and its connections with cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1866, Issue 2, 2016, Pages 330-338

  Penzo, Marianna ^a   Galbiati, Alice ^a   Treré, Davide ^a   Montanaro, Lorenzo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cancer; Methylation; mRNA translation; Pseudouridylation; Ribosome; rRNA modifications

Indexed keywords

ACYLTRANSFERASE; DYSKERIN; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2; MESSENGER RNA; PSEUDOURIDINE; RIBONUCLEOPROTEIN; RIBOSOME RNA; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; TRANSFER RNA;

BINDING SITE; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLON CANCER; DEMETHYLATION; DYSKERATOSIS CONGENITA; GENE CONTROL; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL CARCINOMA; LUNG CANCER; NEOPLASM; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN RNA BINDING; PSEUDOURIDYLATION; REVIEW; RNA ANALYSIS; RNA EDITING; RNA FOLDING; RNA METHYLATION; RNA PROCESSING; RNA SEQUENCE; RNA STRUCTURE; RNA TRANSLATION; GENE EXPRESSION REGULATION; GENETICS; NEOPLASMS;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RNA EDITING; RNA, RIBOSOMAL;

EID: 84994603211     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2016.10.007     Document Type: Review

References (92)

1. [1] Montanaro, L., Treré, D., Derenzini, M., Nucleolus, ribosomes, and cancer. Am. J. Pathol. 173 (2008), 301–310.
2. [2] Montanaro, L., Treré, D., Derenzini, M., Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim. Biophys. Acta 1825 (2012), 101–110.
3. [3] Ruggero, D., Pandolfi, P.P., Does the ribosome translate cancer?. Nat. Rev. Cancer 3 (2003), 179–192.
4. [4] Montanaro, L., Calienni, M., Bertoni, S., Rocchi, L., Sansone, P., Storci, G., Santini, D., Ceccarelli, C., Taffurelli, M., Carnicelli, D., Brigotti, M., Bonafè, M., Treré, D., Derenzini, M., Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res. 70 (2010), 4767–4777.
5. [5] Rocchi, L., Pacilli, A., Sethi, R., Penzo, M., Schneider, R.J., Treré, D., Brigotti, M., Montanaro, L., Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. Nucleic Acids Res. 41 (2013), 8308–8318.
6. [6] Marcel, V., Ghayad, S.E., Belin, S., Therizols, G., Morel, A.-P., Solano-Gonzàlez, E., Vendrell, J.A., Hacot, S., Mertani, H.C., Albaret, M.A., Bourdon, J.-C., Jordan, L., Thompson, A., Tafer, Y., Cong, R., Bouvet, P., Saurin, J.-C., Catez, F., Prats, A.-C., Puisieux, A., Diaz, J.-J., p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 24 (2013), 318–330.
7. [7] Montanaro, L., Brigotti, M., Clohessy, J., Barbieri, S., Ceccarelli, C., Santini, D., Taffurelli, M., Calienni, M., Teruya-Feldstein, J., Trerè, D., Pandolfi, P.P., Derenzini, M., Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J. Pathol. 210 (2006), 10–18.
8. [8] Sharma, S., Lafontaine, D.L.J., “View From A Bridge”: A New Perspective on Eukaryotic rRNA Base Modification. Trends Biochem. Sci. 40 (2015), 560–575.
9. [9] Piekna-Przybylska, D., Decatur, W.A., Fournier, M.J., The 3D rRNA modification maps database: with interactive tools for ribosome analysis. Nucleic Acids Res. 36 (2008), D178–D183.
10. [10] Decatur, W.A., Fournier, M.J., rRNA modifications and ribosome function. Trends Biochem. Sci. 27 (2002), 344–351.
11. [11] Henras, A.K., Plisson-Chastang, C., O'Donohue, M.-F., Chakraborty, A., Gleizes, P.-E., An overview of pre-ribosomal RNA processing in eukaryotes. Wiley Interdiscip. Rev. RNA 6 (2015), 225–242.
12. [12] Melekhovets, Y.F., Good, L., Elela, S.A., Nazar, R.N., Intragenic processing in yeast rRNA is dependent on the 3′ external transcribed spacer. J. Mol. Biol. 239 (1994), 170–180.
13. [13] Weinstein, L.B., Steitz, J.A., Guided tours: from precursor snoRNA to functional snoRNP. Curr. Opin. Cell Biol. 11 (1999), 378–384.
14. [14] Tollervey, D., Lehtonen, H., Jansen, R., Kern, H., Hurt, E.C., Temperature-sensitive mutations demonstrate roles for yeast fibrillarin in pre-rRNA processing, pre-rRNA methylation, and ribosome assembly. Cell 72 (1993), 443–457.
15. [15] Turowski, T.W., Tollervey, D., Cotranscriptional events in eukaryotic ribosome synthesis. Wiley Interdiscip. Rev. RNA 6 (2015), 129–139.
16. [16] Kos, M., Tollervey, D., Yeast pre-rRNA processing and modification occur cotranscriptionally. Mol. Cell 37 (2010), 809–820.
17. [17] Tafforeau, L., Zorbas, C., Langhendries, J.L., Mullineux, S.T., Stamatopoulou, V., Mullier, R., Wacheul, L., Lafontaine, D.L., The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors. Mol. Cell 51 (2013), 539–551.
18. [18] Õunap, K., Käsper, L., Kurg, A., Kurg, R., The human WBSCR22 protein is involved in the biogenesis of the 40S ribosomal subunits in mammalian cells. PLoS One, 8, 2013, e75686.
19. [19] Zorbas, C., Nicolas, E., Wacheul, L., Huvelle, E., Heurgué-Hamard, V., Lafontaine, D.L.J., The human 18S rRNA base methyltransferases DIMT1L and WBSCR22-TRMT112 but not rRNA modification are required for ribosome biogenesis. Mol. Biol. Cell 26 (2015), 2080–2095.
20. [20] Haag, S., Kretschmer, J., Bohnsack, M.T., WBSCR22/Merm1 is required for late nuclear pre-ribosomal RNA processing and mediates N7-methylation of G1639 in human 18S rRNA. RNA 21 (2015), 180–187.
21. [21] Waku, T., Nakajima, Y., Yokoyama, W., Nomura, N., Kako, K., Kobayashi, A., Shimizu, T., Fukamizu, A., NML-mediated rRNA base methylation links ribosomal subunit formation to cell proliferation in a p53-dependent manner. J. Cell Sci., 2016.
22. [22] Ito, S., Akamatsu, Y., Noma, A., Kimura, S., Miyauchi, K., Ikeuchi, Y., Suzuki, T., Suzuki, T., A Single Acetylation of 18 S rRNA Is Essential for Biogenesis of the Small Ribosomal Subunit in Saccharomyces cerevisiae. J. Biol. Chem. 289 (2014), 26201–26212.
23. [23] Sharma, S., Langhendries, J.-L., Watzinger, P., Kötter, P., Entian, K.-D., Lafontaine, D.L.J., Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1/THUMPD1. Nucleic Acids Res. 43 (2015), 2242–2258.
24. [24] Baudin-Baillieu, A., Fabret, C., Liang, X.-H., Piekna-Przybylska, D., Fournier, M.J., Rousset, J.-P., Nucleotide modifications in three functionally important regions of the Saccharomyces cerevisiae ribosome affect translation accuracy. Nucleic Acids Res. 37 (2009), 7665–7677.
25. [25] Liang, X.H., Liu, Q., Fournier, M.J., rRNA modifications in an intersubunit bridge of the ribosome strongly affect both ribosome biogenesis and activity. Mol. Cell 28 (2007), 965–977.
26. [26] Liang, X.-H., Liu, Q., Fournier, M.J., Loss of rRNA modifications in the decoding center of the ribosome impairs translation and strongly delays pre-rRNA processing. RNA 15 (2009), 1716–1728.
27. [27] Charette, M., Gray, M.W., Pseudouridine in RNA: what, where, how, and why. IUBMB Life 49 (2000), 341–351.
28. [28] Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P.H., Cordon-Cardo, C., Pandolfi, P.P., Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299 (2003), 259–262.
29. [29] Yoon, A., Peng, G., Brandenburger, Y., Brandenburg, Y., Zollo, O., Xu, W., Rego, E., Ruggero, D., Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312 (2006), 902–906.
30. [30] Hellen, C.U., Sarnow, P., Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 15 (2001), 1593–1612.
31. [31] Bellodi, C., Krasnykh, O., Haynes, N., Theodoropoulou, M., Peng, G., Montanaro, L., Ruggero, D., Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res. 70 (2010), 6026–6035.
32. [32] Bellodi, C., Kopmar, N., Ruggero, D., Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J. 29 (2010), 1865–1876.
33. [33] Jack, K., Bellodi, C., Landry, D.M., Niederer, R.O., Meskauskas, A., Musalgaonkar, S., Kopmar, N., Krasnykh, O., Dean, A.M., Thompson, S.R., Ruggero, D., Dinman, J.D., rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol. Cell 44 (2011), 660–666.
34. [34] Penzo, M., Rocchi, L., Brugiere, S., Carnicelli, D., Onofrillo, C., Coute, Y., Brigotti, M., Montanaro, L., Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation. FASEB J. 29 (2015), 3472–3482.
35. [35] Jiang, J., Seo, H., Chow, C.S., Post-transcriptional Modifications Modulate rRNA Structure and Ligand Interactions. Acc. Chem. Res. 49 (2016), 893–901.
36. [36] Sumita, M., Jiang, J., SantaLucia, J., Chow, C.S., Comparison of solution conformations and stabilities of modified helix 69 rRNA analogs from bacteria and human. Biopolymers 97 (2012), 94–106.
37. [37] Heiss, N.S., Knight, S.W., Vulliamy, T.J., Klauck, S.M., Wiemann, S., Mason, P.J., Poustka, A., Dokal, I., X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19 (1998), 32–38.
38. [38] Sieron, P., Hader, C., Hatina, J., Engers, R., Wlazlinski, A., Müller, M., Schulz, W.A., DKC1 overexpression associated with prostate cancer progression. Br. J. Cancer 101 (2009), 1410–1416.
39. [39] Alawi, F., Lin, P., Ziober, B., Patel, R., Correlation of dyskerin expression with active proliferation independent of telomerase. Head Neck 33 (2011), 1041–1051.
40. [40] Penzo, M., Ludovini, V., Treré, D., Siggillino, A., Vannucci, J., Bellezza, G., Crinò, L., Montanaro, L., Dyskerin and TERC expression may condition survival in lung cancer patients. Oncotarget 6 (2015), 21755–21760.
41. [41] M. McMahon, A. Contreras, D. Ruggero, Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease., Wiley Interdiscip. Rev. RNA. 6 173–89.
42. [42] Herter, E.K., Stauch, M., Gallant, M., Wolf, E., Raabe, T., Gallant, P., snoRNAs are a novel class of biologically relevant Myc targets. BMC Biol., 13, 2015, 25.
43. [43] Krastev, D.B., Slabicki, M., Paszkowski-Rogacz, M., Hubner, N.C., Junqueira, M., Shevchenko, A., Mann, M., Neugebauer, K.M., Buchholz, F., A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. Nat. Cell Biol. 13 (2011), 809–818.
44. [44] Bellodi, C., McMahon, M., Contreras, A., Juliano, D., Kopmar, N., Nakamura, T., Maltby, D., Burlingame, A., Savage, S.A., Shimamura, A., Ruggero, D., H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep. 3 (2013), 1493–1502.
45. [45] Chaudhuri, S., Vyas, K., Kapasi, P., Komar, A.A., Dinman, J.D., Barik, S., Mazumder, B., Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation. RNA 13 (2007), 2224–2237.
46. [46] Belin, S., Beghin, A., Solano-Gonzàlez, E., Bezin, L., Brunet-Manquat, S., Textoris, J., Prats, A.-C., Mertani, H.C., Dumontet, C., Diaz, J.-J., Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS One, 4, 2009, e7147.
47. [47] Martens-Uzunova, E.S., Hoogstrate, Y., Kalsbeek, A., Pigmans, B., Vredenbregt-van den Berg, M., Dits, N., Nielsen, S.J., Baker, A., Visakorpi, T., Bangma, C., Jenster, G., C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer. Oncotarget 6 (2015), 17430–17444.
48. [48] Dong, X.Y., Guo, P., Boyd, J., Sun, X., Li, Q., Zhou, W., Dong, J.T., Implication of snoRNA U50 in human breast cancer. J Genet Genomics. 36 (2009), 447–454.
49. [49] Pacilli, A., Ceccarelli, C., Treré, D., Montanaro, L., SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. Int. J. Mol. Sci. 14 (2013), 14923–14935.
50. [50] Lafontaine, D., Vandenhaute, J., Tollervey, D., The 18S rRNA dimethylase Dim1p is required for pre-ribosomal RNA processing in yeast. Genes Dev. 9 (1995), 2470–2481.
51. [51] Nakazawa, Y., Arai, H., Fujita, N., The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis. Cancer Res. 71 (2011), 1146–1155.
52. [52] Tiedemann, R.E., Zhu, Y.X., Schmidt, J., Shi, C.X., Sereduk, C., Yin, H., Mousses, S., Stewart, A.K., Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome. Cancer Res. 72 (2012), 757–768.
53. [53] Hayrapetyan, A., Grosjean, H., Helm, M., Effect of a quaternary pentamine on RNA stabilization and enzymatic methylation. Biol. Chem. 390 (2009), 851–861.
54. [54] Motorin, Y., Lyko, F., Helm, M., 5-methylcytosine in RNA: detection, enzymatic formation and biological functions. Nucleic Acids Res. 38 (2010), 1415–1430.
55. [55] Sharma, S., Yang, J., Watzinger, P., Kötter, P., Entian, K.-D., Yeast Nop2 and Rcm1 methylate C2870 and C2278 of the 25S rRNA, respectively. Nucleic Acids Res. 41 (2013), 9062–9076.
56. [56] Bourgeois, G., Ney, M., Gaspar, I., Aigueperse, C., Schaefer, M., Kellner, S., Helm, M., Motorin, Y., Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120. PLoS One, 10, 2015, e0133321.
57. [57] Sato, K., Nishi, T., Takeshima, H., Kochi, M., Kuratsu, J., Masuko, N., Sugimoto, Y., Yamada, Y., Ushio, Y., Expression of p120 nucleolar proliferating antigen in human gliomas and growth suppression of glioma cells by p120 ribozyme vector. Int. J. Oncol. 14 (1999), 417–424.
58. [58] Trerè, D., Migaldi, M., Montanaro, L., Pession, A., Derenzini, M., p120 expression provides a reliable indication of the rapidity of cell duplication in cancer cells independently of tumour origin. J. Pathol. 192 (2000), 216–220.
59. [59] Sato, G., Saijo, Y., Uchiyama, B., Kumano, N., Sugawara, S., Fujimura, S., Sato, M., Sagawa, M., Ohkuda, K., Koike, K., Minami, Y., Satoh, K., Nukiwa, T., Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinoma. J. Clin. Oncol. 17 (1999), 2721–2727.
60. [60] Saijo, Y., Sato, G., Usui, K., Sato, M., Sagawa, M., Kondo, T., Minami, Y., Nukiwa, T., Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma. Ann. Oncol. 12 (2001), 1121–1125.
61. [61] Ventura, L., Migaldi, M., Criscuolo, M., Castelli, M., Barbolini, G., Ranieri, A., Bifaretti, G., Uboldi, P., Leocata, P., Nucleolar protein p120 expression in oral carcinoma. Anticancer Res. 19 (1999), 1423–1426.
62. [62] Shen, Q., Zheng, X., McNutt, M.A., Guang, L., Sun, Y., Wang, J., Gong, Y., Hou, L., Zhang, B., NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp. Cell Res. 315 (2009), 1653–1667.
63. [63] Zhang, H., Hou, W., Wang, H.-L., Liu, H.-J., Jia, X.-Y., Zheng, X.-Z., Zou, Y.-X., Li, X., Hou, L., McNutt, M.A., Zhang, B., GSK-3β-regulated N-acetyltransferase 10 is involved in colorectal cancer invasion. Clin. Cancer Res. 20 (2014), 4717–4729.
64. [64] Piekna-Przybylska, D., Przybylski, P., Baudin-Baillieu, A., Rousset, J.-P., Fournier, M.J., Ribosome performance is enhanced by a rich cluster of pseudouridines in the A-site finger region of the large subunit. J. Biol. Chem. 283 (2008), 26026–26036.
65. [65] Krogh, N., Jansson, M.D., Häfner, S.J., Tehler, D., Birkedal, U., Christensen-Dalsgaard, M., Lund, A.H., Nielsen, H., Profiling of 2′-O-Me in human rRNA reveals a subset of fractionally modified positions and provides evidence for ribosome heterogeneity. Nucleic Acids Res., 2016.
66. [66] Mauro, V.P., Edelman, G.M., The ribosome filter redux. Cell Cycle 6 (2007), 2246–2251.
67. [67] Slavov, N., Semrau, S., Airoldi, E., Budnik, B., van Oudenaarden, A., Differential stoichiometry among core ribosomal proteins. Cell Rep. 13 (2015), 865–873.
68. [68] Xue, S., Barna, M., Specialized ribosomes: a new frontier in gene regulation and organismal biology. Nat. Rev. Mol. Cell Biol. 13 (2012), 355–369, 10.1038/nrm3359.
69. [69] Shi, Z., Barna, M., Translating the genome in time and space: specialized ribosomes, RNA regulons, and RNA-binding proteins. Annu. Rev. Cell Dev. Biol. 31 (2015), 31–54.
70. [70] Spence, J., Gali, R.R., Dittmar, G., Sherman, F., Karin, M., Finley, D., Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain. Cell 102 (2000), 67–76.
71. [71] Moroz, L.L., Edwards, J.R., Puthanveettil, S.V., Kohn, A.B., Ha, T., Heyland, A., Knudsen, B., Sahni, A., Yu, F., Liu, L., Jezzini, S., Lovell, P., Iannucculli, W., Chen, M., Nguyen, T., Sheng, H., Shaw, R., Kalachikov, S., Panchin, Y.V., Farmerie, W., Russo, J.J., Ju, J., Kandel, E.R., Neuronal transcriptome of Aplysia: neuronal compartments and circuitry. Cell 127 (2006), 1453–1467.
72. [72] Bortoluzzi, S., d'Alessi, F., Romualdi, C., Danieli, G.A., Differential expression of genes coding for ribosomal proteins in different human tissues. Bioinformatics 17 (2001), 1152–1157.
73. [73] Kondrashov, N., Pusic, A., Stumpf, C.R., Shimizu, K., Hsieh, A.C., Xue, S., Ishijima, J., Shiroishi, T., Barna, M., Ribosome-Mediated Specificity in Hox mRNA Translation and Vertebrate Tissue Patterning. Cell 145 (2011), 383–397.
74. [74] De Keersmaecker, K., Atak, Z.K., Li, N., Vicente, C., Patchett, S., Girardi, T., Gianfelici, V., Geerdens, E., Clappier, E., Porcu, M., Lahortiga, I., Lucà, R., Yan, J., Hulselmans, G., Vranckx, H., Vandepoel, R., Sweron, B., Jacobs, K., Mentens, N., Wlodarska, I., Cauwelier, B., Cloos, J., Soulier, J., Uyttebroeck, A., Bagni, C., Hassan, B.A., Vandenberghe, P., Johnson, A.W., Aerts, S., Cools, J., Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia., 45, 2013, 186–190.
75. [75] Tzoneva, G., Perez-Garcia, A., Carpenter, Z., Khiabanian, H., Tosello, V., Allegretta, M., Paietta, E., Racevskis, J., Rowe, J.M., Tallman, M.S., Paganin, M., Basso, G., Hof, J., Kirschner-Schwabe, R., Palomero, T., Rabadan, R., Ferrando, A., Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nat. Med. 19 (2013), 368–371.
76. [76] Rao, S., Lee, S.-Y., Gutierrez, A., Perrigoue, J., Thapa, R.J., Tu, Z., Jeffers, J.R., Rhodes, M., Anderson, S., Oravecz, T., Hunger, S.P., Timakhov, R.A., Zhang, R., Balachandran, S., Zambetti, G.P., Testa, J.R., Look, A.T., Wiest, D.L., Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood, 120, 2012.
77. [77] Novetsky, A.P., Zighelboim, I., Thompson, D.M., Powell, M.A., Mutch, D.G., Goodfellow, P.J., Frequent mutations in the RPL22 gene and its clinical and functional implications. Gynecol. Oncol. 128 (2013), 470–474.
78. [78] Zhang, S.-C., Jin, W., Liu, H., Jin, M.-J., Chen, Z.-X., Ding, Z.-Y., Zheng, S.-S., Wang, L.-J., Yu, Y.-X., Chen, K., RPSA Gene Mutants Associated with Risk of Colorectal Cancer among the Chinese Population. Asian Pac. J. Cancer Prev. 14 (2013), 7127–7131.
79. [79] Courtes, F.C., Gu, C., Wong, N.S.C., Dedon, P.C., Yap, M.G.S., Lee, D.-Y., 28S rRNA is inducibly pseudouridylated by the mTOR pathway translational control in CHO cell cultures. J. Biotechnol. 174 (2014), 16–21.
80. [80] Birkedal, U., Christensen-Dalsgaard, M., Krogh, N., Sabarinathan, R., Gorodkin, J., Nielsen, H., Profiling of ribose methylations in RNA by high-throughput sequencing. Angew. Chem. Int. Ed. Eng. 54 (2015), 451–455.
81. [81] Carlile, T.M., Rojas-Duran, M.F., Zinshteyn, B., Shin, H., Bartoli, K.M., Gilbert, W.V., Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature 515 (2014), 143–146.
82. [82] Carlile, T.M., Rojas-Duran, M.F., Gilbert, W.V., Pseudo-Seq: Genome-Wide Detection of Pseudouridine Modifications in RNA. Methods Enzymol. 560 (2015), 219–245.
83. [83] Huang, C., Karijolich, J., Yu, Y.-T., Detection and quantification of RNA 2′-O-methylation and pseudouridylation. Methods, 2016.
84. [84] Penzo, M., Carnicelli, D., Montanaro, L., Brigotti, M., A reconstituted cell-free assay for the evaluation of the intrinsic activity of purified human ribosomes. Nat. Protoc. 11 (2016), 1309–1325.
85. [85] Marcel, V., Catez, F., Diaz, J.-J., Ribosomes: the future of targeted therapies?. Oncotarget 4 (2013), 1554–1555.
86. [86] Rocchi, L., Barbosa, A.J.M., Onofrillo, C., Del Rio, A., Montanaro, L., Inhibition of human dyskerin as a new approach to target ribosome biogenesis. PLoS One, 9, 2014, e101971.
87. [87] Cardones, A.R., Banez, L.L., VEGF inhibitors in cancer therapy. Curr. Pharm. Des. 12 (2006), 387–394.
88. [88] Vassilev, L.T., MDM2 inhibitors for cancer therapy. Trends Mol. Med. 13 (2007), 23–31.
89. [89] Ge, J., Yu, Y.-T., RNA pseudouridylation: new insights into an old modification. Trends Biochem. Sci. 38 (2013), 210–218.
90. [90] Schubert, H.L., Blumenthal, R.M., Cheng, X., Many paths to methyltransfer: a chronicle of convergence. Trends Biochem. Sci. 28 (2003), 329–335.
91. [91] Clawson, G.A., MacDonald, J.R., Woo, C.H., Early hypomethylation of 2′-O-ribose moieties in hepatocyte cytoplasmic ribosomal RNA underlies the protein synthetic defect produced by CCl4. J. Cell Biol. 105 (1987), 705–711.
92. [92] Schosserer, M., Minois, N., Angerer, T.B., Amring, M., Dellago, H., Harreither, E., Calle-Perez, A., Pircher, A., Gerstl, M.P., Pfeifenberger, S., Brandl, C., Sonntagbauer, M., Kriegner, A., Linder, A., Weinhäusel, A., Mohr, T., Steiger, M., Mattanovich, D., Rinnerthaler, M., Karl, T., Sharma, S., Entian, K.-D., Kos, M., Breitenbach, M., Wilson, I.B.H., Polacek, N., Grillari-Voglauer, R., Breitenbach-Koller, L., Grillari, J., Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan. Nat. Commun., 6, 2015, 6158.